Objective
1. Optimization of purification and storage of complement proteins and their distribution to other laboratories.
2. Comparison of monoclonal and polyclonal antibodies and assay reagents testing of their utility in assays of complement component concentrations and complement fixation.
3. Production of selected antibodies and assay reagents on a scale sufficient for distribution.
4. Use of antibodies and assay reagents to screen for complement component deficiencies in patients and controls.
5. Detailed study of complement component interaction with microorganisms of current public health interest.
Human resistance to microbial infection is mediated by humoral and cellular effector systems. A major part of the humoral immune system is complement. Complement consists of a group of 30-35 soluble and cell-surface proteins which recognize and are of utmost importance in the elimination of viruses, bacteria, fungi and multicellular parasites. Complement is a major mediator of clearance of immune complexes, viruses and bacteria from the blood.
Diminished complement activity, arising from genetic defects or from consumption of complement, causes humans to become susceptible to repetitive fulminant or severe infections, and/or to suffer from immune complex deposition diseases, such as systemic lupus erythematosus, rheumatoid arthritis and renal disease. Excessive complement activation, occurring after tissue injury or massive infection, leads to acute or chronic inflammation, and itself directly causes damage to host tissue. The proteins of the complement system are well-characterized at the molecular/biochemical level, and many functions of the proteins are understood from in vitro experiments. In vivo, however, the complexity of function of the complement system is incompletely understood.
The aim of this project is the development/facilitation and coordination of distribution of specialized complement reagents and assay systems, and training in their use for elucidating the role of complement in bacterial, fungal and viral infections
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences health sciences public health
- medical and health sciences clinical medicine rheumatology
- medical and health sciences clinical medicine nephrology
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences basic medicine immunology
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
2333 AA Leiden
Netherlands
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.